欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DK/H/2293/003
药品名称Rosuvastatin "Teva"
活性成分
    • Rosuvastatin calcium 20.0 mg
剂型Film-coated tablet
上市许可持有人Teva B.V. Swensweg 5 2031 GA Haarlem Netherlands
参考成员国 - 产品名称Denmark (DK)
Rosuvastatin "Teva"
互认成员国 - 产品名称
    • Ireland (IE)
    • Portugal (PT)
    • Latvia (LV)
      Rosuvastatin Teva Pharma 20 mg apvalkotās tabletes
    • Lithuania (LT)
      Rosuvastatin Teva Pharma 20 mg plėvele dengtos tabletė
    • Estonia (EE)
    • Hungary (HU)
      ROZUVA-TEVA 20 mg filmtabletta
    • Slovenia (SI)
    • Croatia (HR)
    • Belgium (BE)
      Rosuvastatine Teva 20 mg filmomhulde tabletten/comprimés pelliculés/Filmtabletten
    • Netherlands (NL)
      Rosuvastaine Teva 20 mg, filmomhulde tabletten
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
    • Romania (RO)
      ROSUVASTATINĂ TEVA 20 mg comprimate filmate
    • Austria (AT)
    • Finland (FI)
许可日期2014/09/11
最近更新日期2025/01/30
药物ATC编码
    • C10AA07 rosuvastatin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase